ArticleThe Lancet regional health. Europe2026

Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial.

Georgios Tavoulareas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.